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Sickle cell hemoglobin conveys resistance to malaria. In this issue of Cell Host & Microbe, LaMonte et al.
(2012) demonstrate a surprisingmechanism for this innate immunity. AmicroRNA enriched in sickle red blood
cells is translocated into the parasite, incorporated covalently into P. falciparummRNAs and inhibits parasite
growth.Haldane was the first to suggest that
individuals with the red blood cell dis-
order b-thalassemia are more frequent
in malaria endemic regions because the
mutation confers resistance to the para-
site (Haldane, 1949). Several other red
blood cell disorders are associated with
malaria resistance, including G6PD
deficiency, pyruvate kinase deficiency,
and a-thalassemia. Most strikingly the
variant of the b-globin gene that causes
sickle cell disease, HbS, protects against
clinical malaria caused by infection with
the most virulent species, Plasmodium
falciparum (Hill et al., 1991).
Our current understanding of the
molecular mechanism for this protection
rests on several observations. First, under
conditions of low O2 tension, both homo-
zygous HbSS sickle cells and heterozy-
gous HbAS sickle cell trait cells do not
support growth of P. falciparum, in con-
trast to wild-type HbAA red blood cells
(Pasvol et al., 1978). This was attributed
to the enhanced propensity of HbSS to
polymerize, creating an environment not
conducive to parasite growth. A second
mechanism posits that HbSS erythro-
cytes have an enhanced ability to elicit
immunity, resulting in a more rapid clear-
ance of parasitized erythrocytes (Ayi
et al., 2004). It has also been suggested
that presentation of the major virulence
protein, PfEMP1, on the surface of para-
site-infected erythrocytes is impaired in
HbSS andHbCC red blood cells (Fairhurst
et al., 2005). Recently, a molecular mech-
anism for this altered presentation has
been suggested to result from an aberrant
actin remodeling in HbSS and HbCC red
blood cells (Cyrklaff et al., 2011).LaMonte et al. (2012) now add a further
layer of complexity to the interactions
between the host erythrocyte and the
P. falciparum parasite (Figure 1). They
find that at least two human microRNAs
(miRNAs), miR-451 and miR-233, are
more abundant in both sickle cells and in
the epidemiologically relevant sickle cell
trait cells compared to normal red blood
cells. In tightly controlled experiments,
they show that miR-451 is translocated
into the parasite, where it is incorporated
covalently into P. falciparum mRNAs,
leading to an inhibition of mRNA trans-
lation and a modest but significant
reduction in parasite growth. When
overexpressed in normal erythrocytes,
miR-451 and miR-223 reduced parasite
growth; conversely, blocking the erythro-
cyte to parasite translocation of miR-451
and miR-223, using 20-O-methyl anti-
sense oligonucleotides, diminished ma-
laria resistance in both sickle cells and
sickle cell trait cells.
miRNAs are a recently discovered class
of small noncoding eukaryotic RNAs 18–
24 nucleotides long that downregulate
target genes at a posttranscriptional
level. The majority of miRNA genes are
transcribed by RNA polymerase II into
long primary (pri) miRNA transcripts, pro-
cessed by the nuclear nuclease Drosha
into 60 bp hairpins termed precursor
(pre) miRNAs, and further cleaved in the
cytosol by the Dicer nuclease into mature
miRNAs. Mature miRNAs are then in-
corporated into the multiprotein RNA-
induced silencing complex (RISC), exert-
ingposttranscriptional repression of target
mRNAs, either by inducing mRNA degra-
dation or blocking mRNA translation.Cell Host & Microbe 12Why any miRNAs are present in mature
erythrocytes is a mystery, since there is
no ongoing protein synthesis. Red blood
cell miRNAs like miR-451 and miR-223
are generated during erythroblast pro-
liferation and differentiation, prior to
enucleation. miR-451 is induced during
red blood cell development and is impor-
tant for formation of erythrocytes (Dore
et al., 2008), but it is unclear why it is re-
tained in mature erythrocytes or why its
level is higher in sickle than normal red
blood cells. Experimentally, miRNAs can
be introduced into mature erythrocytes,
so exogenous miR-223 or miR-451 could
possibly be used therapeutically in treat-
ing malaria.
How miRNAs are incorporated into
intracellular malaria parasites is also
unknown. Plasmodium parasites are con-
tained within a parasitophorous vacuolar
membrane, and thus the miRNA would
have to cross from the red blood cell
cytosol through both this membrane and
the parasite’s plasma membrane. Direct
visualization of mir-451 in the parasito-
phorous vacuolar membrane will need to
be reconciled with its activity within the
parasite. There is a precedent for this,
however, as one can use preloaded eryth-
rocytes to introduce plasmid DNA into
the parasite (Deitsch et al., 2001),
although the efficiency of this process is
very low at 1 in 106 cells. It will be of
great interest to elucidate the mechanism
of miRNA translocation, as this may form
the basis for more efficient genetic
manipulation of this Plasmodium species.
Plasmodium parasites do not con-
tain Dicer or any Argonaute homologs
that comprise the RISC complex. RNA, August 16, 2012 ª2012 Elsevier Inc. 127
Figure 1. Model for the Inhibition of Plasmodium falciparum Growth
by Red Blood Cell miRNAs
The P. falciparum parasite invades and grows within the host erythrocyte. Red
blood cell miRNAs, enriched in sickle cells, translocate to the parasite cyto-
plasm, crossing over both the parasitophorous vacuolar membrane and the
parasite plasma membrane. Within the parasite cytoplasm, the miRNAs are
trans-spliced onto the 50 ends of specific parasite mRNA transcripts, forming
miRNA-mRNA chimeras. These chimeras are unable to be loaded onto poly-
ribosomes or translated, resulting in the inhibition of parasite growth.
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conventional functions of
miRNAs, is not functional
in these organisms. Thus,
it was a huge surprise that
the translocated miRNAs
became covalently linked to
certain Plasmodium mRNAs,
forming chimeric RNAs.
Indeed, several transcripts in
a Plasmodium EST database
contain miR-451 at their 50
ends, and this linkage was
subsequently confirmed by
both real-time PCR and
northern blots on parasite
material. Covalent linkage re-
quires a trans-splicing event,
but in unicellular eukaryotes
this has only been observed
in kinetoplastid organisms,
where a leader sequence is
spliced onto the 50 end of all
RNA transcripts during pro-
cessing and maturation (Sut-
ton and Boothroyd, 1986).
InP. falciparum, miRNA tagg-
ing occurs to a minority of
transcripts, including genessuch as PKA-R, PEAMT, and the 28S
and 18S rRNAs. We do not know what
determines the specific enrichment of
certain miRNAs or the incorporation
of these miRNAs to specifc parasite
mRNAs.
This study raises many other questions.
Has increased miRNA-451 or miR-223
expression in red blood cells been
selected for as a malaria resistance
factor, similar to the selection for other
red blood cell disorders? Why does
a reduction in PKA-R result in reduced
parasite proliferation and increased128 Cell Host & Microbe 12, August 16, 2012conversion to sexual stage parasites?
What, if any, are the functional conse-
quences of the other miRNAs differen-
tially regulated between HbSS and
HbAA? Is there conservation of this
mechanism in protection against other
Plasmodium species? What is the relative
contribution of miRNA-based inhibition of
parasite growth in HbSS erythrocytes
compared to other postulated mecha-
nisms of protection, particularly under
low oxygen tension when inhibition of
parasite growth is most marked (Pasvol
et al., 1978)?ª2012 Elsevier Inc.Clearly, Lamonte and
colleagues have revealed a
startling and unique mecha-
nism of cross species trans-
splicing in P. falciparum-in-
fected erythrocytes where
the effector molecule of para-
sitic inhibition is the miRNA
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